Your browser doesn't support javascript.
loading
Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial.
Kogame, Norihiro; Chichareon, Ply; De Wilder, Kenneth; Takahashi, Kuniaki; Modolo, Rodrigo; Chang, Chun Chin; Tomaniak, Mariusz; Komiyama, Hidenori; Chieffo, Alaide; Colombo, Antonio; Garg, Scot; Louvard, Yves; Jüni, Peter; G Steg, Philippe; Hamm, Christian; Vranckx, Pascal; Valgimigli, Marco; Windecker, Stephan; Stoll, Hans-Peter; Onuma, Yoshinobu; Janssens, Luc; Serruys, Patrick W.
  • Kogame N; Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Chichareon P; Department of Cardiology, Toho University medical center Ohashi hospital, Tokyo, Japan.
  • De Wilder K; Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Takahashi K; Faculty of Medicine, Division of Cardiology, Department of Internal Medicine, Prince of Songkla University, Songkhla, Thailand.
  • Modolo R; Heart Centre, Imelda Hospital Bonheiden, Bonheiden, Belgium.
  • Chang CC; Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Tomaniak M; Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Komiyama H; Cardiology Division, Department of Internal Medicine, University of Campinas (UNICAMP), Campinas, Brazil.
  • Chieffo A; Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Colombo A; Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Garg S; Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Louvard Y; Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Jüni P; Interventional Cardiology Unit, Villa Maria Cecila Hospital GVM, Cotignola (RA), Italy.
  • G Steg P; Department of Cardiology, Royal Blackburn Hospital, Blackburn, UK.
  • Hamm C; Department of Cardiology, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Hopital Privé Jacques Cartier, Massy, France.
  • Vranckx P; Applied Health Research Centre, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada.
  • Valgimigli M; Department of Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Windecker S; French Alliance for Cardiovascular Trials (FACT), Université Paris-Diderot, Paris, France.
  • Stoll HP; Kerckhoff Heart and Thorax Center, University of Giessen, Giessen, Germany.
  • Onuma Y; Faculty of Medicine and Life Sciences, Jessa Ziekenhuis, the Hasselt University, Hasselt, Belgium.
  • Janssens L; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.
  • Serruys PW; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.
Catheter Cardiovasc Interv ; 96(1): 100-111, 2020 07.
Article en En | MEDLINE | ID: mdl-31410968

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Agregación Plaquetaria / Antagonistas del Receptor Purinérgico P2Y / Intervención Coronaria Percutánea / Ticagrelor / Terapia Antiplaquetaria Doble / Infarto del Miocardio Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Agregación Plaquetaria / Antagonistas del Receptor Purinérgico P2Y / Intervención Coronaria Percutánea / Ticagrelor / Terapia Antiplaquetaria Doble / Infarto del Miocardio Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article